CANC Tema Oncology ETF

19

NASDAQ | ETF

Price
$27.89
Decreased by -0.14%
Dollar volume (20D)
64.56 K
ADR%
0.89
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology.

The fund is non-diversified.

Top 20 Holdings

Asset Name Sector Industry Weight
AZN AstraZeneca PLC Healthcare Drug Manufacturers - General 5.57%
AMGN Amgen Inc Healthcare Drug Manufacturers - General 5.52%
REGN Regeneron Pharmaceuticals Inc Healthcare Biotechnology 5.43%
GILD Gilead Sciences Inc Healthcare Drug Manufacturers - General 4.50%
ARGX argenx NV ADR Healthcare Biotechnology 3.90%
ILMN Illumina Inc Healthcare Diagnostics & Research 3.84%
RVMD Revolution Medicines Inc Healthcare Biotechnology 3.70%
4519 Chugai Pharmaceutical Co. Ltd. Healthcare Drug Manufacturers - General 3.47%
INCY Incyte Corporation Healthcare Biotechnology 3.41%
4568 Daiichi Sankyo Co. Ltd. Healthcare Drug Manufacturers - General 3.13%
BPMC Blueprint Medicines Corp Healthcare Biotechnology 3.10%
IMGN ImmunoGen Inc Healthcare Biotechnology 3.00%
MREO Mereo BioPharma Group PLC ADR Healthcare Biotechnology 2.81%
MRK Merck & Company Inc Healthcare Drug Manufacturers - General 2.77%
BGNE BeiGene Ltd Healthcare Biotechnology 2.51%
EXEL Exelixis Inc Healthcare Biotechnology 2.32%
CRSP Crispr Therapeutics AG Healthcare Biotechnology 2.31%
EXAS EXACT Sciences Corporation Healthcare Diagnostics & Research 2.26%
NOVN Novartis AG Healthcare Drug Manufacturers - General 2.21%
AGIO Agios Pharm Healthcare Biotechnology 2.19%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY